Verastem reported $56K in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Cytokinetics CYTK:US $ 2.81M 0.06M
Epizyme EPZM:US $ 370K 0
Gilead Sciences GILD:US $ 242M 4M
Immunogen IMGN:US $ 1.08M 0.17M
Laboratory Of America LH:US $ 42.5M 0.3M
Novartis NOVN:VX 202M 1000K
Pfizer PFE:US $ 293M 29M
Tg Therapeutics TGTX:US $ 2.66M 1.58M
Verastem VSTM:US $ 0.06M 0.05M
YTE INCY:US $ 0.68M 0M
Ziopharm Oncology ZIOP:US 683K 55K